Lexicon Pharmaceuticals(LXRX) - 2026 Q2 - Earnings Call Presentation
SecondQuarter 2026 Earnings A u g u s t 6 , 2026 3 Highlights SONATA-HCM Enrollment Complete Pivotal study of sotagliflozin fully randomized; topline data anticipated Q1 2027 Forward-Looking Statements 2 • This presentation, including any oral presentation accompanying it, contains "forward-looking statements," including statements about Lexicon's strategy and operating performance and events or developments that we expect or anticipate will occur in the future, such as projections of our future results of ...